A hypothetical Democratic majority in Congress should move quickly to reverse Trump-era health care policies in the first 100 hours of the 120th Congress by taking up existing -- or forthcoming -- ...

The deadline for state Medicaid agencies to finalize their decision on whether to participate in the Trump administration’s model testing the ability of "most favored nation” pricing to bring down the ...

The much-anticipated final rule updating requirements for insurers and group health plans to publish negotiated prices has cleared the White House Office of Management and Budget.

The Senate will return next week with little chance of passing substantive legislation before the midterm elections, with the House already out, but some movement is planned on HHS nominees before ...

A trade association representing long-term care pharmacies (LTCs) is hoping CMS will use an upcoming request for information to establish guidance on contracting issues like reimbursement rates and ...

Senate Finance Committee members say documents show CMS plans to expand its controversial, AI-driven Medicare prior authorization model to review time-sensitive medical services like oncology care and ...

FDA’s Prescription Drug Use Related Software (PDURS) guidance last week advanced to the White House Office of Management and Budget (OMB) for review, drawing praise in a LinkedIn post from the ...

The House Ways & Means Committee will mark up Wednesday (Sept. 16) an amended version of legislation backed by Medicare Advantage stakeholders that aims to ensure Congress’ Medicare payment advisors ...

Public health advocacy organizations, including some patient advocacy groups pushing for increased access to rare disease treatments, say they’re concerned FDA’s PDUFA VIII draft caters to the drug ...

Some digital health experts are concerned that CMS' ACCESS program may further fragment the physician-patient relationship through reliance on wellness devices that often do not connect patients with ...

A District of Columbia judge is letting the Trump administration collect and share more information about recipients of aid from HHS’ Administration for Children and Families ahead of the deadline in ...

Only four drug companies are expected to qualify for CMS’ scaled-back model to test Medicare Part B rebates to meet “most favored nation” (MFN) pricing, with drug industry experts suspecting three of ...